Reported May 14, 2014 · Terminated
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by
Wockhardt USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wockhardt Usa Inc. · 20 Waterview Blvd., Suite 3 · Parsippany, NJ · 07054
Is this the product you have?
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Wockhardt Limited, Mumbai, India |
| 2 | Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA |
| 3 | NDC 64679-735-09, UPC 3 64679 73509 1. |
- Lot codes and dates
Lot #: LN10686LN10687LN10688LN10707LN10708Exp 02/15
- Amount recalled
- 109,744 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wockhardt USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.